(1.02%) 5 099.96 points
(0.40%) 38 240 points
(2.03%) 15 928 points
(-0.85%) $83.14
(-1.16%) $1.619
(-0.34%) $2 339.30
(-0.11%) $27.51
(0.52%) $926.90
(-0.19%) $0.933
(-0.18%) $11.00
(-0.26%) $0.798
(0.00%) $92.17
Live Chart Being Loaded With Signals
PharmaCyte Biotech, Inc., a biotechnology company, focuses on developing and commercializing cellular therapies for cancer, diabetes, and malignant ascites in the United States...
Stats | |
---|---|
本日の出来高 | 5 596.00 |
平均出来高 | 25 331.00 |
時価総額 | 17.86M |
EPS | $0 ( 2024-03-15 ) |
Last Dividend | $0 ( N/A ) |
Next Dividend | $0 ( N/A ) |
P/E | -1.430 |
ATR14 | $0.0170 (0.81%) |
Date | Person | Action | Amount | type |
---|---|---|---|---|
2023-11-20 | Weinstein Robert | Buy | 61 248 | Stock Option (Right to Buy) |
2023-11-20 | Walker Wayne Remell | Buy | 61 248 | Stock Option (Right to Buy) |
2023-11-20 | Trujillo Carlos | Buy | 85 000 | Stock Option (Right to Buy) |
2023-11-20 | Silverman Joshua | Buy | 170 000 | Stock Option (Right to Buy) |
2023-11-20 | Schechter Jonathan | Buy | 61 248 | Stock Option (Right to Buy) |
INSIDER POWER |
---|
56.19 |
Last 54 transactions |
Buy: 749 992 | Sell: 831 346 |
PharmaCyte Biotech, Inc. 相関
10 最も正の相関 |
---|
10 最も負の相関 |
---|
知っていましたか?
相関は、2つの変数間の関係を説明する統計的指標です。相関係数は-1から1までの値を取り、-1は完全な負の相関(1つの変数が増加すると、もう一方は減少する)、1は完全な正の相関(1つの変数が増加すると、もう一方も増加する)、0は相関がないことを示します(変数間に関係がない)。
相関は、株式だけでなく、どの2つの変数間の関係にも適用できます。これは、金融、経済学、心理学などの分野で一般的に使用されています。
PharmaCyte Biotech, Inc. 財務諸表
Annual | 2023 |
収益: | $0 |
総利益: | $0 (0.00 %) |
EPS: | $-0.220 |
FY | 2023 |
収益: | $0 |
総利益: | $0 (0.00 %) |
EPS: | $-0.220 |
FY | 2022 |
収益: | $0 |
総利益: | $0 (0.00 %) |
EPS: | $-0.260 |
FY | 2021 |
収益: | $0.00 |
総利益: | $0.00 (0.00 %) |
EPS: | $-2.45 |
Financial Reports:
No articles found.
PharmaCyte Biotech, Inc.
PharmaCyte Biotech, Inc., a biotechnology company, focuses on developing and commercializing cellular therapies for cancer, diabetes, and malignant ascites in the United States. Its cellular therapies are developed based on Cell-in-a-Box, a proprietary cellulose-based live cell encapsulation technology used as a platform to treat various types of cancer, including advanced and inoperable pancreatic cancer, as well as diabetes. The company is developing therapies for pancreatic and other solid cancerous tumors; a therapy for Type 1 diabetes and insulin-dependent Type 2 diabetes, which include encapsulated genetically modified insulin-producing cells; and therapies for cancer based on the constituents of the cannabis plant. It has a research agreement with the University of Technology, Sydney to create a version of melligen cells to treat diabetes; and the University of Northern Colorado to develop methods for the identification, separation, and quantification of constituents of cannabis. The company was formerly known as Nuvilex, Inc. and changed its name to PharmaCyte Biotech, Inc. in January 2015. PharmaCyte Biotech, Inc. was incorporated in 1996 and is headquartered in Las Vegas, Nevada.
について ライブシグナル
このページで提示されるライブシグナルは、NA を買う時や売る時を判断するのに役立ちます。シグナルには1分以上の遅延があります。市場シグナルには誤りやミスの可能性があるため、ライブ取引シグナルは決定的ではなく、getagraph.comはこれらのシグナルに基づく任意の行動について責任を負いません。詳細については、利用規約で説明されているように、技術分析指標に基づいています。